1. Systemic oxidative stress in children with cystic fibrosis with bacterial infection including Pseudomonas Aeruginosa.
- Author
-
Bennemann GD, Moreira EAM, Pereira LCR, de Freitas MB, de Oliveira D, Ventura JC, Parisotto EB, Moreno YMF, Trindade EBSM, Barbosa E, Ludwig Neto N, and Wilhelm Filho D
- Subjects
- Child, Preschool, Cross-Sectional Studies, Glutathione metabolism, Humans, Oxidative Stress, Pseudomonas aeruginosa, Thiobarbituric Acid Reactive Substances metabolism, Bacterial Infections, Cystic Fibrosis microbiology
- Abstract
Introduction: Oxidative stress (OS) occurs in cystic fibrosis (CF)., Objective: The objective of this work is to evaluate the influence of bacterial infection on biomarkers of OS (catalase [CAT], glutathione peroxidade [GPx], reduced glutathione [GSH]), markers of oxidative damage (protein carbonyls [PC], thiobarbituric acid reactive substances [TBARS]), together with the nutritional status and lung function in children with CF., Methods: Cross-sectional study including CF group (CFG, n = 55) and control group (CG, n = 31), median age: 3.89 and 4.62 years, respectively. CFG was distributed into CFG negative bacteriology (CFGB-, n = 27) or CFG positive bacteriology (CFGB+, n = 28), and CFG negative Pseudomonas aeruginosa (CFGPa-, n = 36) or CFG positive Pseudomonas aeruginosa (CFGPa+, n = 19)., Results: Compared with CG, CFG (P = .034) and CFGB+ (P = .042) had lower body mass index-for-age z-score; forced expiratory volume in the first second was lower in CFGB+ and CFGPa+ (both P < .001). After adjusting for confounders and compared with CG: CFG showed higher TBARS (P ≤ .001) and PC (P = .048), and lower CAT (P = .004) and GPx (P = .003); the increase in PC levels was observed in CFGB+ (P = .011) and CFGPa+ (P = .001) but not in CFGB- (P = .510) and CFGPa- (P = .460)., Conclusions: These results indicate a systemic OS in children with CF. The presence of bacterial infection particularly Pseudomonas aeruginosa seems to be determinant to exacerbate the oxidative damage to proteins, in which PC may be a useful biomarker of OS in CF., (© 2022 The Authors. The Clinical Respiratory Journal published by John Wiley & Sons Ltd.)
- Published
- 2022
- Full Text
- View/download PDF